Allurion Technologies Announced Results Of Research Showing Impact Of Growing Interest In Anti-Obesity Medications On Allurion Program Awareness And Uptake
Portfolio Pulse from Benzinga Newsdesk
Allurion Technologies conducted research showing that nearly 90% of healthcare professionals (HCPs) consider the Allurion Program an ideal first-line treatment for achieving over 10% body weight loss quickly and sustainably. The study involved 172 HCPs and 1663 patients across 64 countries, assessing the impact of growing interest in anti-obesity medications on the awareness and uptake of the Allurion Program.

January 05, 2024 | 1:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Allurion Technologies' research indicates strong support from healthcare professionals for its weight loss program, which could lead to increased adoption and revenue growth.
The positive research results and high endorsement rate from healthcare professionals suggest that Allurion Technologies' Allurion Program could see increased demand and usage. This could translate into higher revenues and a positive market perception, potentially boosting the stock price in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80